CORE--CLINICAL INVESTIGATIONS SHARED RESOURCE

描述：（申请人描述）临床研究中心的活动 调查共享资源围绕患者转诊 办公室此资源提供给San Francisco的成员调查人员 安东尼奥癌症研究所，以支持适当的转诊和快速 完成同行评审，资助的临床研究项目， 由制药商发起的试点研究。 患者转诊办公室是患者获得 癌症中心的临床试验患者转诊协调员接受 医生、病人和其他人的电话询问， 临床试验的可用性。通过邮件联系也被解决 通过这个办公室的电话患者转诊协调员可以 通过电话评估初步患者资格，收集临床数据 进行审查，并安排由SACI医生-调查员进行评估。 自1997年1月1日以来，该办公室已受理了1，255个电话 关于进入临床试验或癌症的信息。这些电话可能很简短， 单个联系人或多个联系人发起几个小时的对话， 协调员和推荐人之间的多次跟进电话 肿瘤学家、患者、方案研究者和癌症中心人员。 患者转诊协调员配备为呼叫者提供最多- 所有治疗性临床研究的最新合格性和治疗 在该癌症中心进行的研究，包括所有合作小组 研究，NCI I期合作协议研究，制药商发起 机构试点研究和制药公司赞助的研究 根据SACI实验治疗计划进行，以及 NSABP乳腺癌预防试验，组间前列腺癌 预防试验，并转诊进行SACI癌症评估 预防和风险评估诊所， SACI癌症预防和健康促进以及乳腺癌方案。 病人转诊办公室已成为一个重要的核心组成部分， 我们癌症中心与社区和其他 癌症治疗设施。该办公室提供了一个有效的机制， 为了确保临床试验与 患者的治疗需求。值得注意的是，患者转诊 协调员对临床研究项目的特殊价值 SACI是她的专业水平，在获得深入的信息，从 来电者关于他们的治疗需求，来电者的潜力， 参与SACI临床试验，并制定切实可行的计划， 来电者对我们的环境或另一种癌症的进一步评估 中心

Description: (Applicant's Description) The activities of the Clinical Investigations Shared Resource are centered around the Patient Referral Office. This resource is offered to member-investigators of the San Antonio Cancer Institute to support appropriate referral to and rapid completion of peer reviewed, funded clinical research projects and investigator-initiated pilot studies. The Patient Referral Office is the primary venue for patient access to cancer center clinical trials. The Patient Referral Coordinator accepts telephone inquiries from physicians, patients and others about the availability of clinical trials. Contacts by mail are also addressed through phone calls from this office. The Patient Referral Coordinator can assess preliminary patient eligibility by phone, assemble clinical data for review, and arrange an evaluation by a SACI physician-investigator. Since January 1, 1997, this office has accepted 1,255 telephone calls about access to clinical trials or cancer. These calls may be brief, single contacts or many initiate several hours or conversation and multiple follow-up calls between the coordinator and the referring oncologist, patient, protocol investigators and cancer center personnel. The Patient Referral Coordinator is equipped to provide callers with up- to-date eligibility and treatment about all therapeutic clinical research studies conducted at this cancer center, including all cooperative group studies, NCI Phase I Cooperative Agreement studies, investigator-initiated institutional pilot studies, and pharmaceutical company-sponsored studies conducted under the SACI Experimental Therapeutics Program, as well as the NSABP Breast Cancer Prevention Trial, the Intergroup Prostate Cancer Prevention Trial, and referrals for evaluation in the SACI Cancer Prevention and Risk Assessment Clinic related to studies conduced by the SACI Cancer Prevention and Health Promotion and Breast Cancer Programs. The Patient Referral Office has become an essential and central component of our cancer center's interactions with the community and with other cancer treatment facilities. The office provides an efficient mechanism for assuring the highest likelihood of matching a clinical trial with a patient's treatment needs. It is noteworthy that the Patient Referral Coordinator's special value to the clinical investigations programs of the SACI is her level of expertise in obtaining in-depth information from callers about their treatment needs, the caller's potential for participation in a SACI clinical trial, and developing realistic plans for the caller's further evaluation in our setting or that of another cancer center.